Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial · scientific article · YYNN

Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

? TBD

scientific article

Ratings
0

Nobody has rated this yet. Be the first!

Lists
0

Instance of

Scholarly article

Author

David A Reardon

Astrid Weyerbrock

Rafał Tarnawski

Alba A. Brandes

Martin J van den Bent

Kenneth D Aldape

Rolf-Dieter Kortmann

Ulrich Herrlinger

Catherine McBain

Jörg-Christian Tonn

Martin Taphoorn

Subject

phase III clinical trial

Multicenter trial

Wikidata